CYTOVANCE BIOLOGICS INC - Sep 30, 2024 Form SCHEDULE 13G/A Schedule Report for GT Biopharma, Inc. (GTBP)

Filing Manager: CYTOVANCE BIOLOGICS INC
Reporting Manager: CYTOVANCE BIOLOGICS INC
Security: GT Biopharma, Inc. Common Stock, par value $0.001
Symbol: GTBP
Shares outstanding: 2.24M shares
Disclosed Ownership: 219K shares
Ownership: 9.8%
Form type: SCHEDULE 13G/A
Date filed: 10/17/2024, 11:15 AM
Date of event: Sep 30, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
CYTOVANCE BIOLOGICS INC	9.8%	219K	219K	0	David Knauss	Secretary and Treasurer